Results of a new study released today by UCLA suggests that a class of drug commonly prescribed to treat depression might have another health benefit by helping the immune system attack cancer.
Results of a study released Thursday by UCLA suggests that a class of drug commonly prescribed to treat depression might have another health benefit by helping.
A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the medications work by boosting levels of serotonin, the